These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 26027432)

  • 21. Etoposide loaded layered double hydroxide nanoparticles reversing chemoresistance and eradicating human glioma stem cells in vitro and in vivo.
    Wang Z; Liang P; He X; Wu B; Liu Q; Xu Z; Wu H; Liu Z; Qian Y; Wang S; Zhu R
    Nanoscale; 2018 Jul; 10(27):13106-13121. PubMed ID: 29961791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
    Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
    Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts.
    Okada M; Suzuki S; Togashi K; Sugai A; Yamamoto M; Kitanaka C
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting glioblastoma stem cells (GSCs) with peroxisome proliferator-activated receptor gamma (PPARγ) ligands.
    Im CN
    IUBMB Life; 2016 Mar; 68(3):173-7. PubMed ID: 26818439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells.
    Kuramoto K; Yamamoto M; Suzuki S; Sanomachi T; Togashi K; Seino S; Kitanaka C; Okada M
    FEBS J; 2020 May; 287(10):2023-2036. PubMed ID: 31868973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma cancer stem cell biology: Potential theranostic targets.
    Sharifzad F; Ghavami S; Verdi J; Mardpour S; Mollapour Sisakht M; Azizi Z; Taghikhani A; Łos MJ; Fakharian E; Ebrahimi M; Hamidieh AA
    Drug Resist Updat; 2019 Jan; 42():35-45. PubMed ID: 30877905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells.
    Hu X; Wu N; Xia P; Yu S; Sun F; Chen J
    Cancer Chemother Pharmacol; 2012 May; 69(5):1205-12. PubMed ID: 22258403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic targeting of malignant glioma.
    Alexandru-Abrams D; Jadus MR; Hsu FP; Stathopoulos A; Bota DA
    Anticancer Agents Med Chem; 2014; 14(8):1075-84. PubMed ID: 25175690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells.
    Kardani K; Sanchez Gil J; Rabkin SD
    Front Cell Infect Microbiol; 2023; 13():1206111. PubMed ID: 37325516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma.
    Sørensen MD; Fosmark S; Hellwege S; Beier D; Kristensen BW; Beier CP
    Adv Exp Med Biol; 2015; 853():111-38. PubMed ID: 25895710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
    Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture.
    Haley EM; Kim Y
    Cancer Lett; 2014 Apr; 346(1):1-5. PubMed ID: 24333730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel nor-monoterpenoid indole alkaloids inhibiting glioma stem cells from fruits of Alstonia scholaris.
    Wang B; Dai Z; Yang XW; Liu YP; Khan A; Yang ZF; Huang WY; Wang XH; Zhao XD; Luo XD
    Phytomedicine; 2018 Sep; 48():170-178. PubMed ID: 30195875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.
    Suwala AK; Hanaford A; Kahlert UD; Maciaczyk J
    J Neuropathol Exp Neurol; 2016 May; 75(5):388-96. PubMed ID: 26979081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salinomycin's potential to eliminate glioblastoma stem cells and treat glioblastoma multiforme (Review).
    Magrath JW; Kim Y
    Int J Oncol; 2017 Sep; 51(3):753-759. PubMed ID: 28766685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay.
    Glantz M; Kesari S; Recht L; Fleischhack G; Van Horn A
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S17-24. PubMed ID: 19660679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells.
    Kawamura Y; Takouda J; Yoshimoto K; Nakashima K
    Cell Biol Toxicol; 2018 Dec; 34(6):425-440. PubMed ID: 29383547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional CDK Inhibitors CYC065 and THZ1 Induce Apoptosis in Glioma Stem Cells Derived from Recurrent GBM.
    Juric V; Düssmann H; Lamfers MLM; Prehn JHM; Rehm M; Murphy BM
    Cells; 2021 May; 10(5):. PubMed ID: 34066147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.